4-Sep-2026
No headlines found.
No press releases found.
No news found.
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Invesco Biotechnology & Genome ETF trades on the ARCA stock market under the symbol PBE.
As of September 4, 2026, PBE stock price declined to $97.64 with 7,220 million shares trading.
PBE has a beta of 0.54, meaning it tends to be less sensitive to market movements. PBE has a correlation of 0.14 to the broad based SPY ETF.
PBE has a market cap of $423.74 million. This is considered a Small Cap stock.
In the last 3 years, PBE traded as high as $98.82 and as low as $52.47.
PBE has outperformed the market in the last year with a return of +41.2%, while the SPY ETF gained +19.8%. In the last 3 month period, PBE beat the market returning +16.9%, while SPY returned +2.0%. However, in the most recent 2 weeks PBE has underperformed the stock market by returning 0.0%, while SPY returned +0.6%.
PBE support price is $97.47 and resistance is $99.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PBE shares will trade within this expected range on the day.
